Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells. Its primary objective is to unlock the potential of its proprietary technology platforms and intellectual property, enabling to be at the forefront of developing next-generation CAR T-cell therapies. By fully leveraging its innovative technology platforms, Celyad Oncology aims to maximize the transformative impact of its candidate CAR T-cell therapies and redefine the future of CAR T-cell treatments. Celyad Oncology is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.
Company Details
- Employees
- 32
- Founded
- -
- Address
- 9 Rue André Dumont, Mont-Saint-Guibert,1435,belgium
- Phone
- +32(0) 10 39 41 00
- in****@****3bs.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- celyad.com
- HQ
- Mont-Saint-Guibert
Celyad Oncology Questions
Celyad Oncology's helpline number is +32(0) 10 39 41 00
Celyad Oncology's website is celyad.com
Celyad Oncology's LinkedIn profile is https://be.linkedin.com/company/celyadoncology
Celyad Oncology has
32 employees.
View email and phone details for 32
employees at Celyad Oncology.
Celyad Oncology's industry is
Biotechnology Research
Celyad Oncology's top competitors are
Cellaïon,
Esobiotec,
Cellistic,
Novadip Biosciences S.a.,
Oncodna,
Biosenic S.a.,
Iteos Therapeutics,
Univercells,
Quantoom Biosciences,
Exothera.
Celyad Oncology's support email address is info@c3bs.com
Celyad Oncology's categories are Biotechnology Research
Celyad Oncology's founding year is 2007
